Related Experiment Video
Updated: May 10, 2026

11:24
Direct Protein Delivery to Mammalian Cells Using Cell-permeable Cys2-His2 Zinc-finger Domains
Published on: March 25, 2015
DNAzyme delivery approaches in biological settings
Cecilia W S Chan1, Levon M Khachigian
1Centre for Vascular Research, University of New South Wales, Sydney, NSW 2052, Australia.
Current Medicinal Chemistry
|June 11, 2013
Summary
DNAzymes, or DNA-based catalysts, show promise for treating genetic disorders. Overcoming cellular delivery challenges is key to their development as novel therapeutic drugs.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Discovery
Background:
- DNAzymes are catalytic DNA molecules with therapeutic potential for various diseases.
- Current DNAzyme applications are limited by challenges in efficient cellular delivery, especially for systemic treatments.
Purpose of the Study:
- To review existing DNAzyme delivery methods.
- To explore future strategies for enhancing DNAzyme delivery and therapeutic utility.
Main Methods:
- Review of literature on DNAzyme delivery systems.
- Analysis of different carrier agents like polymers and liposomes.
- Discussion of naked DNAzyme delivery approaches.
Main Results:
- Various delivery methods for DNAzymes have been explored, including naked delivery and carrier-assisted approaches.
- Efficient cellular uptake remains a significant hurdle for widespread DNAzyme application.
Conclusions:
- Improved DNAzyme delivery systems are crucial for realizing their potential as novel therapeutic agents.
- Future research should focus on innovative methodologies to enhance DNAzyme delivery and efficacy.
Related Concept Videos
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...

